Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2021.03.26

CII-SR EHS Excellence Awards

Sai Life Sciences manufacturing facility achieves 5-star rating at CII-SR EHS Excellence Awards

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRO/ CDMO), today announced that its flagship manufacturing facility in Bidar, Karnataka received a 5-star rating for excellence in EHS practices at the 13th edition of the Confederation of Indian Industry’s (CII-SR) EHS Excellence Awards. This is the second consecutive year that the site is achieving this recognition.

Receiving the award on behalf of Sai Life Sciences, Sreekrishna Chopperla, Vice President & Head – Corporate Health, Safety & Environment said, “At Sai Life Sciences, we go the extra mile in ensuring employee safety and environment protection, both by designing world-class facilities as well as in sustaining them through robust processes. We’re truly honoured to receive this recognition and consider it a responsibility to uphold sustainable HSE practices in everything we do.”

The Bidar manufacturing facility of Sai Life Sciences has been on a path of significant expansion with the site production capacity growing from 230KL in 2017 to 400KL today and on course to be 600KL by the end of 2021. Along the way it has ensured stringent safety, quality and environmental controls. Here are some of the highlights:

• Zero Liquid Discharge facility.
• Achieved zero waste to landfill
• Advanced containment systems capable of minimising chemical exposure below 1 µg/m3
• In-house capability for monitoring chemical exposure, heat stress, personal noise dosimetry to personnel

More details about the company’s HSE practices can be viewed in its Sustainability Report 2020.

This recognition comes on the back of a highly successful year from a Sustainability perspective. Some of the highlights:

• Became the first India-headquartered company to join the PSCI membership.
• Received the ISO 14001:2015 and ISO 45001:2018 certifications for its R&D facility, manufacturing site and corporate office.
• Joined ACS Green Chemistry Institute Pharmaceutical Roundtable (ACS-GCIPR) as an ‘Associate Member’.
• Won the prestigious 21st National Award for Excellence in Energy Management 2020 by CII - Sohrabji Godrej Green Business Centre
• Released its first Sustainability Report 2019-20 as per the GRI framework

Further, through its proactive response to the COVID-19 pandemic, the company ensured minimal impact on its stakeholders and business operations by safeguarding workforce, ensuring business continuity with its supplier and customers, and supporting the community.

Share article

More News

2025.08.28

Sai Life Sciences completes Phase II of Production Block 11 at Bidar site, India, expands capacity to 700 KL

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the completion of Phase II of its new Production Block (PB-11) at the company’s flagship API manufacturing facility in Bidar, India (Unit IV). The Phase I of PB-11, with a capacity of 110 KL, was inaugurated […]
Read more

2025.08.20

Sai Life Sciences secures SBTi validation for near-term climate targets

Sai Life Sciences Limited, an innovator focused Contract Research, Development, and Manufacturing Organization (CRDMO), announced that its near-term targets to cut greenhouse gas (GHG) emissions have been validated by the Science Based Targets initiative (SBTi)—a corporate climate action organization that enables companies and financial institutions worldwide to play their part in combating the climate crisis. […]
Read more

2025.08.20

Sai Life Sciences featured in Drug Discovery & Development on trends shaping drug discovery

Sai Life Sciences was recently featured in Drug Discovery & Development, where Dr Maneesh Pingle, Executive Vice President and Head of Discovery Services, shared insights on the emerging trends in pharma sector. A key focus was the impact of GLP 1 agonists in accelerating peptide drug discovery. Dr. Pingle explained how the success of these […]
Read more

2025.08.13

Peptide Science & Beyond: Masterclass & Fireside Chat with IISc Professor, Dr. Jayanta Chatterjee

Sai Life Sciences recently hosted Dr. Jayanta Chatterjee, Associate Professor at the Indian Institute of Science (IISc), Bangalore, for two enriching sessions at its campus. The first was the Masterclass Lecture Series, where Dr. Chatterjee addressed a group of scientists at Sai Life Sciences on “Our Adventures in the de novo Design of Helical Macrocyclic […]
Read more

2025.08.13

From vendor to vanguard: Reimagining India’s role in global life sciences

In a recent article published in ET Edge titled, ‘From Vendor to Vanguard: Reimagining India’s Role in Global Life Sciences,’ Krishna Kanumuri, MD & CEO, Sai Life Sciences, highlighted India’s rapidly unfolding transformation from a vendor to an innovation leader in the global life sciences ecosystem.You can read the full article here: From vendor to vanguard: […]
Read more